Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02477124 · ClinicalTrials.gov registry record · NA
A See and Treat Paradigm for Cervical Pre-cancer
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 514
- Enrollment target
NCT02477124: Clinical Trial NA study, sponsored by Duke University.
NCT02477124 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 514 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02477124, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 514 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the transvaginal colposcope produces similar results to colposcopy for the screening of cervical cancer. In this study the investigators are using an investigational device called the transvaginal colposcope. The word investigational means that the device is still being tested in research studies and is not approved by the U.S. Food and Drug Administration (FDA).
Interventions
- DEVICE transvaginal digital colposcope (TVDC)
- OTHER Standard of care screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 514 participants |
| Start Date | 2015-09 |
| Est. Completion | 2020-03 |
| Phase | NA |
Why NCT02477124 stopped before completion
NCT02477124 is an interventional study that assigns participants to a tested intervention. The registered 514 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 2 interventions - of which transvaginal digital colposcope (TVDC) is the first listed.
NCT02477124 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02477124 about?
NCT02477124 is a clinical study titled "A See and Treat Paradigm for Cervical Pre-cancer". The purpose of this study is to see if the transvaginal colposcope produces similar results to colposcopy for the screening of cervical cancer. In this study the investigators are using an investigational device called the transvaginal colposcope. The word investigational means that the device is st...
What is the current status of trial NCT02477124?
This trial is currently terminated. It is a NA study. The enrollment target is 514 participants. The study started on 2015-09. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02477124?
The interventions under investigation include: transvaginal digital colposcope (TVDC) (DEVICE), Standard of care screening (OTHER).
Who is sponsoring clinical trial NCT02477124?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02477124's enrollment target sits among peer trials
514 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- NCT06585488 · 514 participants · Phase 1
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
- NCT06716606 · 514 participants · Phase 3
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia